Minerva Neurosciences Inc (NERV)
2.38
-0.02
(-0.83%)
USD |
NASDAQ |
May 02, 12:25
Minerva Neurosciences 1 Year Total Returns (Daily): -36.17% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 01, 2024 | -36.17% |
| April 30, 2024 | -15.72% |
| April 29, 2024 | -13.93% |
| April 26, 2024 | -6.29% |
| April 25, 2024 | 4.29% |
| April 24, 2024 | 5.43% |
| April 23, 2024 | 2.85% |
| April 22, 2024 | 3.66% |
| April 19, 2024 | -18.95% |
| April 18, 2024 | -13.19% |
| April 17, 2024 | -10.51% |
| April 16, 2024 | 9.65% |
| April 15, 2024 | 6.14% |
| April 12, 2024 | 17.37% |
| April 11, 2024 | 9.96% |
| April 10, 2024 | 36.83% |
| April 09, 2024 | 55.83% |
| April 08, 2024 | 55.83% |
| April 05, 2024 | 56.79% |
| April 04, 2024 | 56.66% |
| April 03, 2024 | 53.05% |
| April 02, 2024 | 57.19% |
| April 01, 2024 | 58.12% |
| March 28, 2024 | 52.66% |
| March 27, 2024 | 52.44% |
| Date | Value |
|---|---|
| March 26, 2024 | 54.82% |
| March 25, 2024 | 60.24% |
| March 22, 2024 | 56.99% |
| March 21, 2024 | 53.25% |
| March 20, 2024 | 69.81% |
| March 19, 2024 | 65.62% |
| March 18, 2024 | 68.75% |
| March 15, 2024 | 60.34% |
| March 14, 2024 | 54.49% |
| March 13, 2024 | 63.95% |
| March 12, 2024 | 66.37% |
| March 11, 2024 | 68.77% |
| March 08, 2024 | 49.73% |
| March 07, 2024 | 26.43% |
| March 06, 2024 | 25.60% |
| March 05, 2024 | 23.81% |
| March 04, 2024 | 22.86% |
| March 01, 2024 | 24.64% |
| February 29, 2024 | 23.61% |
| February 28, 2024 | 31.02% |
| February 27, 2024 | 32.39% |
| February 26, 2024 | 216.3% |
| February 23, 2024 | 198.7% |
| February 22, 2024 | 216.6% |
| February 21, 2024 | 289.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-88.89%
Minimum
May 18 2022
351.0%
Maximum
Dec 28 2023
-14.07%
Average
-41.90%
Median
Sep 02 2021
1 Year Total Returns (Daily) Benchmarks
| Viking Therapeutics Inc | 245.5% |
| Janux Therapeutics Inc | 279.1% |
| ACADIA Pharmaceuticals Inc | -21.66% |
| Karyopharm Therapeutics Inc | -71.95% |
| Calidi Biotherapeutics Inc | -98.12% |